Alpelisib Active Not Recruiting Phase 1 Trials for Cancer, Breast / Cancer of the Ovary Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01872260Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
NCT02167854Open-Label Study Evaluating the Safety and Tolerability of LJM716, BYL719 and Trastuzumab in Patients With Metastatic HER2+ Breast Cancer
NCT01623349Phase I Study of the Oral PI3kinase Inhibitor BKM120 or BYL719 and the Oral PARP Inhibitor Olaparib in Patients With Recurrent Triple Negative Breast Cancer or High Grade Serous Ovarian Cancer